Medline Inc. (MDLN) stock
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3063% above fair value
$37.84−1.32 (-3.37%)
Close on Nov 19, 2026Market cap $49.75BP/E –Yield –
Medline gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Medline's gross profit for the twelve months ending Sep 26, 2026 was $7.90B. For fiscal 2025 it was $7.52B, up 7.8% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.52B | +7.8% |
| FY2024 | Dec 31, 2024 | $6.98B | +18.5% |
| FY2023 | Dec 31, 2023 | $5.89B | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $1.93B | +2.7% |
| Q2 FY2026 | Jun 27, 2026 | $2.22B | +16.3% |
| Q1 FY2026 | Mar 28, 2026 | $1.84B | +0.9% |
| Q4 FY2025 | Dec 31, 2025 | $1.91B | – |
| Q3 FY2025 | Sep 27, 2025 | $1.88B | – |
| Q2 FY2025 | Jun 28, 2025 | $1.91B | – |
| Q1 FY2025 | Mar 29, 2025 | $1.82B | – |
See a number that looks wrong?